Author:
Giuliano Anna R.,Joura Elmar A.,Garland Suzanne M.,Huh Warner K.,Iversen Ole-Erik,Kjaer Susanne K.,Ferenczy Alex,Kurman Robert J.,Ronnett Brigitte M.,Stoler Mark H.,Bautista Oliver M.,Moeller Erin,Ritter Michael,Shields Christine,Luxembourg Alain
Funder
Merck Sharp & Dohme Corp.
MSD
Subject
Obstetrics and Gynaecology,Oncology
Reference29 articles.
1. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study;de Sanjose;Lancet Oncol.,2010
2. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide;Alemany;Int. J. Cancer,2015
3. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine;Garland;J. Infect. Dis.,2009
4. Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease;Joura;Cancer Epidemiol. Biomark. Prev.,2014
5. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions;Serrano;Eur. J. Cancer,2015
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献